Frequently bought together

Brand : GLIPTAMET

GLIPTAMET 50/1000/MG FC TAB 56/FC TAB

106.4

Sku : I-013580
Key features
GLIPTAMET 50/1000 mg film-coated tablets contain sitagliptin phosphate 50 mg and metformin hydrochloride 1000 mg as active ingredients. Metformin lowers hepatic glucose production, reduces intestinal glucose absorption and improves insulin sensitivity, while sitagliptin inhibits DPP‑4 to increase endogenous incretins (GLP‑1 and GIP), enhancing glucose‑dependent insulin secretion and suppressing glucagon. It is used to improve glycemic control in adults with type 2 diabetes mellitus. Available as film-coated tablets in packs of 56; prescription only.
- Brand: GLIPTAMET
- Active Ingredient: METFORMIN HYDROCHLORIDE 1000mg, SITAGLIPTIN PHOSPHATE 50mg
- Strength: 1000,50mg
- Dosage Form: Film-coated tablet
- Pack Size: 56 Tablets
- Route: Oral use
- Prescription Status: Prescription
- Therapeutic Class: Antidiabetic
- Pharmacological Group: Oral Antidiabetics
- Manufacturer: PATHEON INC
- Country of Origin: Puerto Rico
- SFDA Registration No.: 2307257840
- Shelf Life: 24 months
- Storage: do not store above 30°c
- Diabetes Type: Type 2

Frequently bought together

Description

Specification

Pharmacology

Mechanism of Action

Metformin decreases hepatic glucose production, decreases intestinal glucose absorption, and improves insulin sensitivity; sitagliptin inhibits DPP-4, increasing endogenous incretins (GLP-1/GIP) to enhance glucose-dependent insulin secretion and suppress glucagon.

Product Information

Diabetes Type

Type 2

Legal Disclaimer - Al Mujtama Pharmacy The product information provided is derived from verified pharmaceutical references and is intended for general health education only. It is not a substitute for professional medical advice, diagnosis, or treatment. Al Mujtama Pharmacy assumes no legal or medical liability for: Any therapeutic decision made based on the information displayed without consulting a licensed physician or pharmacist Any discrepancy between the information provided and the product's package insert or SFDA guidelines Any misuse of medication resulting from personal interpretation of the content displayed Important notice: Drug formulations and instructions may vary between production batches. Always rely on the leaflet included inside the product packaging you have, and consult your pharmacist or physician before starting, adjusting, or discontinuing any medication. By using this content, you acknowledge that you have read this disclaimer and agree that Al Mujtama Pharmacy bears no liability arising from reliance on this information as a substitute for direct medical consultation. Your health is a trust - always consult your doctor first.